跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SERETIDE MDI 50/25 inhalation - pressurised aerosol can - metered dose (with counter) - TGA Drug Approval Details
Approvals
/
TGA
/
SERETIDE MDI 50/25 inhalation - pressurised aerosol can - metered dose (with counter)
Approved
STANDARD
SERETIDE MDI 50/25 inhalation - pressurised aerosol can - metered dose (with counter)
GlaxoSmithKline Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
1b5a3ff64d5bb6d7
Company
GlaxoSmithKline Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
1b5a3ff64d5bb6d7
Product Name
SERETIDE MDI 50/25 inhalation - pressurised aerosol can - metered dose (with counter)
Artg Id
120661
Artg Name
SERETIDE MDI 50/25 inhalation - pressurised aerosol can - metered dose (with counter)
Sponsor
GlaxoSmithKline Australia Pty Ltd
Company Detail Path
/organization/glaxosmithkline-australia-pty-ltd
Artg Date
2005-09-26
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2014-CMI-01470-1
Product Information
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2010-PI-05260-3
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
1b5a3ff64d5bb6d7
Type
Standard
Back to TGA Approvals